BR9916575A - Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa - Google Patents

Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa

Info

Publication number
BR9916575A
BR9916575A BR9916575-9A BR9916575A BR9916575A BR 9916575 A BR9916575 A BR 9916575A BR 9916575 A BR9916575 A BR 9916575A BR 9916575 A BR9916575 A BR 9916575A
Authority
BR
Brazil
Prior art keywords
pharmaceutical composition
active substance
controlled release
tilidine mesylate
mesylate
Prior art date
Application number
BR9916575-9A
Other languages
English (en)
Inventor
Richard Hirsch
Martin Wesseling
Thomas Struengmann
Original Assignee
Hexal Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hexal Ag filed Critical Hexal Ag
Publication of BR9916575A publication Critical patent/BR9916575A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Emergency Medicine (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

Patente de Invenção:<B>"COMPOSIçãO FARMACêUTICA DE LIBERAçãO CONTROLADA COM MESILATO DE TILIDINA COMO SUBSTâNCIA- ATIVA"<D>. A invenção refere-se a uma composição farmacêutica sólida, para administração oral, com liberação controlada, que contém mesilato de tilidina como substância ativa.
BR9916575-9A 1998-12-23 1999-12-23 Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa BR9916575A (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19859636A DE19859636A1 (de) 1998-12-23 1998-12-23 Kontrolliert freisetzende pharmazeutische Zusammensetzung mit Tilidinmesylat als Wirkstoff
PCT/EP1999/010381 WO2000038656A1 (de) 1998-12-23 1999-12-23 Kontrolliert freisetzende pharmazeutische zusammensetzung mit tilidinmesylat als wirkstoff

Publications (1)

Publication Number Publication Date
BR9916575A true BR9916575A (pt) 2001-09-18

Family

ID=7892368

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9916575-9A BR9916575A (pt) 1998-12-23 1999-12-23 Composição farmacêutica de liberação controlada com mesilato de tilidina como substância-ativa

Country Status (21)

Country Link
US (1) US6579536B1 (pt)
EP (1) EP1140031B1 (pt)
JP (1) JP2002533381A (pt)
AT (1) ATE252377T1 (pt)
AU (1) AU770293B2 (pt)
BR (1) BR9916575A (pt)
CA (1) CA2355891A1 (pt)
CZ (1) CZ301628B6 (pt)
DE (2) DE19859636A1 (pt)
DK (1) DK1140031T3 (pt)
ES (1) ES2207334T3 (pt)
HU (1) HUP0104647A3 (pt)
MX (1) MXPA01006493A (pt)
NO (1) NO320022B1 (pt)
NZ (1) NZ512079A (pt)
PL (1) PL199024B1 (pt)
PT (1) PT1140031E (pt)
SK (1) SK284901B6 (pt)
TR (1) TR200101864T2 (pt)
WO (1) WO2000038656A1 (pt)
ZA (1) ZA200105040B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200001942T2 (tr) 1997-12-22 2000-11-21 Euro-Celtique, S.A. Opioid agonist/antagonist kombinasyonlar
US6375957B1 (en) 1997-12-22 2002-04-23 Euro-Celtique, S.A. Opioid agonist/opioid antagonist/acetaminophen combinations
CA2400578C (en) * 2000-02-08 2007-01-02 Euro-Celtique, S.A. Controlled-release compositions containing opioid agonist and antagonist
SI2283842T1 (sl) * 2000-02-08 2015-07-31 Euro-Celtique S.A. Oralne formulacije opioidnih agonistov, varne pred zlorabo
EP1387673B1 (en) 2001-05-11 2010-12-29 Endo Pharmaceuticals Inc. Abuse-resistant controlled-release opioid dosage form
LT2425821T (lt) 2002-04-05 2017-07-25 Euro-Celtique S.A. Farmacinis preparatas, turintis oksikodono ir naloksono
JP4563642B2 (ja) * 2002-05-31 2010-10-13 ワトソン ラボラトリーズ、インコーポレイテッド 医薬製剤
DE10233108A1 (de) * 2002-07-20 2004-01-29 Krewel Meuselbach Gmbh Retardiertes Schmerzmittel enthaltend Tilidin und ein Lichtschutzmittel
DE10250081A1 (de) * 2002-10-25 2004-05-13 Boehringer Ingelheim Vetmedica Gmbh Wasserlösliche Meloxicam Granulate
EP1479381A1 (en) * 2003-05-19 2004-11-24 Euro-Celtique S.A. Pharmaceutical dosage form comprising a solid solution
EP1604666A1 (en) 2004-06-08 2005-12-14 Euro-Celtique S.A. Opioids for the treatment of the Chronic Obstructive Pulmonary Disease (COPD)
WO2006009403A1 (en) * 2004-07-22 2006-01-26 Amorepacific Corporation Sustained-release preparations containing topiramate and the producing method thereof
EP1702558A1 (en) 2005-02-28 2006-09-20 Euro-Celtique S.A. Method and device for the assessment of bowel function
US20070048373A1 (en) * 2005-08-30 2007-03-01 Cima Labs Inc. Dried milled granulate and methods
EP2168945A1 (en) * 2008-09-26 2010-03-31 Hexal Ag Crystalline forms of Tilidine Mesylate
WO2010099508A1 (en) 2009-02-26 2010-09-02 Theraquest Biosciences, Inc. Extended release oral pharmaceutical compositions of 3-hydroxy-n-methylmorphinan and method of use
PL2405915T3 (pl) 2009-03-10 2019-05-31 Euro Celtique Sa Kompozycje farmaceutyczne o natychmiastowym uwalnianiu zawierające oksykodon i nalokson
KR20160034352A (ko) 2013-07-23 2016-03-29 유로-셀티큐 에스.에이. 장내 세균총이상을 초래하고/하거나 장내 박테리아 전위에 대한 위험을 증가시키는 질환과 통증으로 인해 고통받고 있는 환자에서 통증을 치료하는데 사용하기 위한 옥시코돈과 날록손의 조합물
BR112017005574A2 (pt) 2014-09-19 2017-12-12 Procter & Gamble formas de dosagem de liberação pulsada de fenilefrina
US10278930B2 (en) 2017-03-16 2019-05-07 The Procter & Gamble Company Method for relieving sinus congestion

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
LU71847A1 (pt) * 1975-02-14 1977-01-05
KR100310041B1 (ko) * 1992-10-26 2002-04-24 괴데케악티엔게젤샤프트 틸리딘이수소오르토포스페이트,그제조방법및이를함유한의약제제
US5965161A (en) * 1994-11-04 1999-10-12 Euro-Celtique, S.A. Extruded multi-particulates
DE19710008A1 (de) 1997-03-12 1998-09-17 Basf Ag Feste, mindestens zweiphasige Zubereitungsformen eines Opioid-Analgeticums mit verzögerter Freisetzung
DE19981795T1 (de) * 1998-04-28 2001-05-10 Russinsky Ltd Tilidinmesylat, Verfahren zu dessen Herstellung und pharmazeutische Zusammensetzung davon

Also Published As

Publication number Publication date
CZ301628B6 (cs) 2010-05-05
ATE252377T1 (de) 2003-11-15
CA2355891A1 (en) 2000-07-06
US6579536B1 (en) 2003-06-17
DE59907481D1 (de) 2003-11-27
NO20013060L (no) 2001-06-20
SK8922001A3 (en) 2001-12-03
DK1140031T3 (da) 2003-12-01
NO320022B1 (no) 2005-10-10
MXPA01006493A (es) 2002-06-04
WO2000038656A1 (de) 2000-07-06
AU770293B2 (en) 2004-02-19
EP1140031B1 (de) 2003-10-22
PT1140031E (pt) 2004-03-31
EP1140031A1 (de) 2001-10-10
TR200101864T2 (tr) 2002-01-21
HK1039273A1 (en) 2002-04-19
SK284901B6 (sk) 2006-02-02
HUP0104647A3 (en) 2003-12-29
JP2002533381A (ja) 2002-10-08
NZ512079A (en) 2003-08-29
PL199024B1 (pl) 2008-08-29
HUP0104647A2 (hu) 2002-03-28
AU2286200A (en) 2000-07-31
DE19859636A1 (de) 2000-06-29
PL348419A1 (en) 2002-05-20
CZ20012167A3 (cs) 2001-11-14
ZA200105040B (en) 2002-05-22
ES2207334T3 (es) 2004-05-16
NO20013060D0 (no) 2001-06-20

Similar Documents

Publication Publication Date Title
BR9611802A (pt) Composições farmacêuticas
BR0314356A (pt) Formulações de liberação retardada para administração oral de um agente terapêutico polipetìdeo e métodos utilizando as mesmas
BR9909565A (pt) Derivados bicìclicos do ácido hidroxâmico
BR9914251A (pt) Formulações orais de liberação sustentada
ES2156603T3 (es) Medicamentos a base de una mezcla sinergetica de metronidazol y de clindamicina.
BR0015188A (pt) Composições farmacêuticas
BR9810495A (pt) Composição farmacêutica
BR0207726A (pt) Sais farmacêuticos
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
BR0207871A (pt) Composição para liberar bisfosfonato para um alvo
EP1539122A4 (en) PHARMACEUTICAL AQUEOUS 2,6-DIISOPROPYLPHENOL COMPOSITIONS
BR0306870A (pt) Composição farmacêutica oral, e, método para preparar a mesma
AU2845599A (en) Pharmaceutical compositions and their use
NO20013060L (no) Kontrollert frigjörende farmasöytisk preparat med tilidinmesylat som virkestoff
ATE260650T1 (de) Orale darreichungsformen zur verabreichung einer fixen kombination von tramadol und diclofenac
AR021934A1 (es) Composicion de administracion oral con liberacion controlada de al menos un analgesico
PT1121127E (pt) Composicoes farmaceuticas orais contendo buprenorfina
ES2176296T3 (es) Composiciones farmaceuticas que permiten la liberacion prolongada de trimetacidina despues de la administracion por via oral.
BR9812553A (pt) Formulação medicamentosa com liberação de substância ativa controlada
BRPI0413013A (pt) composto, seus sais, solvatos, e derivados farmaceuticamente funcionais, composição farmacêutica, uso de um composto, e, métodos para o tratamento ou profilaxia de condições ou distúrbios, e de doenças
BRPI0410623A (pt) composto, processo para preparação de um composto, composição farmacêutica, e, utilização de um composto
BR0114395A (pt) Composição farmacêutica para administração por suprimento via oral
ECSP066860A (es) Formulaciones de matriz oral que comprenden licarbazepina
BRPI0406734A (pt) Composição termiticida, e, método para controlar térmitas
BR0015781A (pt) Composição farmacêutica para tratamento de doenças associadas à diminuição de massa óssea

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 6A E 7A ANUIDADES

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 1922 DE 06/11/2007.